BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24867421)

  • 21. Preparation and antitumor evaluation of hinokiflavone hybrid micelles with mitochondria targeted for lung adenocarcinoma treatment.
    Chen Y; Feng X; Li L; Song K; Zhang L
    Drug Deliv; 2020 Dec; 27(1):565-574. PubMed ID: 32252563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
    Gao W; Xiang B; Meng TT; Liu F; Qi XR
    Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
    Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y
    Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and characteristics of lipid nanoemulsion formulations loaded with doxorubicin.
    Jiang SP; He SN; Li YL; Feng DL; Lu XY; Du YZ; Yu HY; Hu FQ; Yuan H
    Int J Nanomedicine; 2013; 8():3141-50. PubMed ID: 23990722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PEGylated polypeptide lipid nanocapsules to enhance the anticancer efficacy of erlotinib in non-small cell lung cancer.
    Kim J; Ramasamy T; Choi JY; Kim ST; Youn YS; Choi HG; Yong CS; Kim JO
    Colloids Surf B Biointerfaces; 2017 Feb; 150():393-401. PubMed ID: 27825759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyaluronic acid coated PLGA nanoparticulate docetaxel effectively targets and suppresses orthotopic human lung cancer.
    Wu J; Deng C; Meng F; Zhang J; Sun H; Zhong Z
    J Control Release; 2017 Aug; 259():76-82. PubMed ID: 28027947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted delivery of ginsenoside compound K using TPGS/PEG-PCL mixed micelles for effective treatment of lung cancer.
    Yang L; Zhang Z; Hou J; Jin X; Ke Z; Liu D; Du M; Jia X; Lv H
    Int J Nanomedicine; 2017; 12():7653-7667. PubMed ID: 29089761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
    Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
    Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer.
    Tan BJ; Liu Y; Chang KL; Lim BK; Chiu GN
    Int J Nanomedicine; 2012; 7():651-61. PubMed ID: 22334787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy.
    Wang L; Li M; Zhang N
    Int J Nanomedicine; 2012; 7():3281-94. PubMed ID: 22802688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-interactive mPEG-
    Gong F; Wang R; Zhu Z; Duan J; Teng X; Cui ZK
    Drug Deliv; 2020 Dec; 27(1):238-247. PubMed ID: 32003299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumour microenvironment-responsive lipoic acid nanoparticles for targeted delivery of docetaxel to lung cancer.
    Gu F; Hu C; Tai Z; Yao C; Tian J; Zhang L; Xia Q; Gong C; Gao Y; Gao S
    Sci Rep; 2016 Nov; 6():36281. PubMed ID: 27805051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
    Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
    Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhalation delivery of a novel diindolylmethane derivative for the treatment of lung cancer.
    Ichite N; Chougule M; Patel AR; Jackson T; Safe S; Singh M
    Mol Cancer Ther; 2010 Nov; 9(11):3003-14. PubMed ID: 20978159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response of pH-Sensitive Doxorubicin Nanoparticles on Complex Tumor Microenvironments by Tailoring Multiple Physicochemical Properties.
    Chen H; Luo Q; Wang J; He H; Luo W; Zhang L; Xiao Q; Chen T; Xu X; Niu W; Ke Y; Wang Y
    ACS Appl Mater Interfaces; 2020 May; 12(20):22673-22686. PubMed ID: 32337980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gelatinase-stimuli strategy enhances the tumor delivery and therapeutic efficacy of docetaxel-loaded poly(ethylene glycol)-poly(ɛ-caprolactone) nanoparticles.
    Liu Q; Li RT; Qian HQ; Yang M; Zhu ZS; Wu W; Qian XP; Yu LX; Jiang XQ; Liu BR
    Int J Nanomedicine; 2012; 7():281-95. PubMed ID: 22287839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RGD-modified PEGylated paclitaxel nanocrystals with enhanced stability and tumor-targeting capability.
    Huang ZG; Lv FM; Wang J; Cao SJ; Liu ZP; Liu Y; Lu WY
    Int J Pharm; 2019 Feb; 556():217-225. PubMed ID: 30557679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and antitumor evaluation of self-assembling oleanolic acid-loaded Pluronic P105/d-α-tocopheryl polyethylene glycol succinate mixed micelles for non-small-cell lung cancer treatment.
    Wu H; Zhong Q; Zhong R; Huang H; Xia Z; Ke Z; Zhang Z; Song J; Jia X
    Int J Nanomedicine; 2016; 11():6337-6352. PubMed ID: 27932881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor homing cell penetrating peptide decorated nanoparticles used for enhancing tumor targeting delivery and therapy.
    Gao H; Zhang Q; Yang Y; Jiang X; He Q
    Int J Pharm; 2015 Jan; 478(1):240-250. PubMed ID: 25448586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system.
    Lee SW; Yun MH; Jeong SW; In CH; Kim JY; Seo MH; Pai CM; Kim SO
    J Control Release; 2011 Oct; 155(2):262-71. PubMed ID: 21704664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.